Skip to content

Clinical trials

Withdrawn Phase 1/2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Phase: Phase 1/2 Status: Withdrawn Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20131
20141
20171
20181
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Michigan Rogel Cancer Center2
Bio-Path Holdings, Inc.1
Columbia University1
Fred Hutchinson Cancer Center1
Hadassah Medical Organization1
Naoyuki G. Saito, M.D., Ph.D.1
Sheba Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive8
Leukemia, Myeloid, Acute3
Myelodysplastic Syndromes3
Leukemia2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Graft vs Host Disease1
Leukemia, Lymphocytic, Chronic, B-Cell1
Leukemia, Myeloid, Chronic-Phase1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.